News

Varying dialysate calcium dosage not tied to differences in all-cause, cardiovascular mortality

20 Oct: Varying dialysate calcium dosage not tied to differences in all-cause, cardiovascular mortality

There are no significant differences in all-cause or cardiovascular mortality with the prescription of dialysate calcium 1.50 versus 1.25 mmol/L for patients undergoing hemodialysis, according to a study published online Oct. 4 in the Clinical Kidney Journal. Karlien J. ter Meulen, from Maastricht University Medical Centre in the Netherlands, and colleagues investigated the association between

Trial analysis shows vitamin D supplementation doesn’t cut cardiac risk

19 Oct: Trial analysis shows vitamin D supplementation doesn’t cut cardiac risk

Graphical abstract Geometric means (95 % confidence intervals) of (A) high-sensitivity cardiac troponin I (hs-cTnI, ng/L), a marker of cardiac injury, and (B) N-terminal pro-b-type natriuretic peptide (NT-proBNP, pg/mL), a marker of cardiac strain, according to vitamin D3 supplementation assignment at baseline (Bl) and after 3-month, 12-month, and 24-month periods. Credit: American Journal of Preventive

Controlled trial shows hearing and vision health support vital in dementia care

15 Oct: Controlled trial shows hearing and vision health support vital in dementia care

Trial profile. Credit: The Lancet Healthy Longevity (2024). DOI: 10.1016/j.lanhl.2024.07.008 A new study across five European countries is the largest randomized controlled trial to date evaluating the efficacy of a combined hearing and vision rehabilitation intervention for people with dementia living at home. The new study led by Trinity College and the Global Brain Health